Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Baptiste Garsi

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Journal of Organic Chemistry|November 9, 2021
Design of Pseudodiproline Dimers as Mimetics of Pro-Pro Units: Stereocontrolled Synthesis, Configurational Relevance, and Structural PropertiesJean-Baptiste Garsi, Pedro M Aguiar, Stephen Hanessian
ACS Omega|November 2, 2020
Ni-Catalyzed Reductive and Merged Photocatalytic Cross-Coupling Reactions toward sp<sup>3</sup>/sp<sup>2</sup>-Functionalized Isoquinolones: Creating Diversity at C-6 and C-7 to Address Bioactive AnaloguesAdrien Dumas, Jean-Baptiste Garsi, Guillaume Poissonnet, et al.
The Journal of Organic Chemistry|March 15, 2024
Pseudodiproline (Pro-Cyp) Oligomers Fold into Helical Polyproline Type secondary structuresJean-Baptiste Garsi, Pedro M Aguiar, Gilles Berger, et al.
The Journal of Organic Chemistry|July 28, 2022
2-Oxa-5-azabicyclo[2.2.1]heptane as a Platform for Functional Diversity: Synthesis of Backbone-Constrained γ-Amino Acid AnaloguesJean-Baptiste Garsi, Solène Guggari, Thomas Deis, et al.
European Journal of Medicinal Chemistry|October 8, 2018
In search of constrained FTY720 and phytosphingosine analogs as dual acting anticancer agents targeting metabolic and epigenetic pathwaysJean-Baptiste Garsi, Lorenzo Sernissi, Vito Vece, et al.
ACS Medicinal Chemistry Letters|July 14, 2026
Design and Synthesis of Phosphonoproline-Proline Bioisosteric Mimetics of Proline Dimers: Pseudopeptide Constructs as Potential Inhibitors of the Zn-Metalloprotease PPEP‑1 Associated with <i>Clostridioides difficile</i>Erick Ivan Martinez Toto, Sofiane Hocine, Jean-Baptiste Garsi, et al.
Bioorganic & Medicinal Chemistry Letters|July 16, 2024
Revisiting the dipeptidyl carboxypeptidase inhibitor captopril as a source of pan anti-trypanosomatid agentsJean-Baptiste Garsi, Sofiane Hocine, Raphaël Hensienne, et al.
Bioorganic & Medicinal Chemistry Letters|August 7, 2019
Design, synthesis and anticancer activity of constrained sphingolipid-phenoxazine/phenothiazine hybrid constructs targeting protein phosphatase 2AJean-Baptiste Garsi, Vito Vece, Lorenzo Sernissi, et al.
ACS Medicinal Chemistry Letters|June 16, 2022
Targeting NOX2 via p47/phox-p22/phox Inhibition with Novel Triproline MimeticsJean-Baptiste Garsi, Balázs Komjáti, Gregorio Cullia, et al.
The EMBO Journal|June 30, 2025
Sphingosine simultaneously inhibits nuclear import and activates PP2A by binding importins and PPP2R1AVaishali Jayashankar, Peter Kubiniok, Alison N McCracken, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Journal of Organic Chemistry|November 9, 2021
Design of Pseudodiproline Dimers as Mimetics of Pro-Pro Units: Stereocontrolled Synthesis, Configurational Relevance, and Structural PropertiesJean-Baptiste Garsi, Pedro M Aguiar, Stephen Hanessian
ACS Omega|November 2, 2020
Ni-Catalyzed Reductive and Merged Photocatalytic Cross-Coupling Reactions toward sp<sup>3</sup>/sp<sup>2</sup>-Functionalized Isoquinolones: Creating Diversity at C-6 and C-7 to Address Bioactive AnaloguesAdrien Dumas, Jean-Baptiste Garsi, Guillaume Poissonnet, et al.
The Journal of Organic Chemistry|March 15, 2024
Pseudodiproline (Pro-Cyp) Oligomers Fold into Helical Polyproline Type secondary structuresJean-Baptiste Garsi, Pedro M Aguiar, Gilles Berger, et al.
The Journal of Organic Chemistry|July 28, 2022
2-Oxa-5-azabicyclo[2.2.1]heptane as a Platform for Functional Diversity: Synthesis of Backbone-Constrained γ-Amino Acid AnaloguesJean-Baptiste Garsi, Solène Guggari, Thomas Deis, et al.
European Journal of Medicinal Chemistry|October 8, 2018
In search of constrained FTY720 and phytosphingosine analogs as dual acting anticancer agents targeting metabolic and epigenetic pathwaysJean-Baptiste Garsi, Lorenzo Sernissi, Vito Vece, et al.
ACS Medicinal Chemistry Letters|July 14, 2026
Design and Synthesis of Phosphonoproline-Proline Bioisosteric Mimetics of Proline Dimers: Pseudopeptide Constructs as Potential Inhibitors of the Zn-Metalloprotease PPEP‑1 Associated with <i>Clostridioides difficile</i>Erick Ivan Martinez Toto, Sofiane Hocine, Jean-Baptiste Garsi, et al.
Bioorganic & Medicinal Chemistry Letters|July 16, 2024
Revisiting the dipeptidyl carboxypeptidase inhibitor captopril as a source of pan anti-trypanosomatid agentsJean-Baptiste Garsi, Sofiane Hocine, Raphaël Hensienne, et al.
Bioorganic & Medicinal Chemistry Letters|August 7, 2019
Design, synthesis and anticancer activity of constrained sphingolipid-phenoxazine/phenothiazine hybrid constructs targeting protein phosphatase 2AJean-Baptiste Garsi, Vito Vece, Lorenzo Sernissi, et al.
ACS Medicinal Chemistry Letters|June 16, 2022
Targeting NOX2 via p47/phox-p22/phox Inhibition with Novel Triproline MimeticsJean-Baptiste Garsi, Balázs Komjáti, Gregorio Cullia, et al.
The EMBO Journal|June 30, 2025
Sphingosine simultaneously inhibits nuclear import and activates PP2A by binding importins and PPP2R1AVaishali Jayashankar, Peter Kubiniok, Alison N McCracken, et al.
Pageof 1